Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AFFIMED N.V.

(AFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AFFIMED N.V.
10/12AFFIMED N : SVB Leerink Adjusts Price Target on Affimed to $12 From $13, Maintains Outperf..
MT
10/04AFFIMED N : Announces Acceptance of Three Abstracts with Preclinical Data on Its Innate Ce..
AQ
10/01AFFIMED N : Announces Acceptance of Three Abstracts with Preclinical Data on Its Innate Ce..
GL
10/01Affimed Announces Acceptance of Three Abstracts with Preclinical Data on Its Innate Cel..
GL
10/01Affimed Announces Acceptance of Three Abstracts with Preclinical Data on Its Innate Cel..
CI
09/30AFFIMED N : Stifel Starts Affimed at Buy With $12 Price Target
MT
09/25AFFIMED N : 2021 Virtual Cantor Fitzgerald Healthcare Conference
PU
09/08AFFIMED N : Earnings Flash (AFMD) AFFIMED N.V. Posts Q2 Revenue $9.71M, vs. Street Est of ..
MT
09/08AFFIMED N : UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Form 6-K)
PU
09/08AFFIMED N : Q2 Loss Flat, Revenue Rises
MT
09/08Affimed Reports Second Quarter 2021 Financial Results and Highlights Operational Progre..
GL
09/07AFFIMED N : 2021 Virtual Wells Fargo Healthcare Conference
PU
09/06AFFIMED N : Second Quarter 2021 Financial Results and Corporate Update Conference Call
PU
08/26AFFIMED N : to Present at Upcoming Investor Conferences
AQ
08/23AFFIMED N : to Report Second Quarter 2021 Financial Results & Corporate Update on Septembe..
AQ
08/02AFFIMED N : Announces Publication of Comprehensive Preclinical Data Demonstrating the Ther..
AQ
07/30AFFIMED N : Announces Publication of Comprehensive Preclinical Data Demonstrating the Ther..
AQ
07/30Affimed N.V. Announces Publication of Comprehensive Preclinical Data Demonstrating the ..
CI
07/01AFFIMED N : Q1 Revenue Advances
MT
07/01AFFIMED N : Unaudited consolidated statements of comprehensive income / (loss) (in € thous..
PU
07/01AFFIMED N : Reports First Quarter 2021 Financial Results and Highlights Operational Progre..
PU
07/01Affimed Reports First Quarter 2021 Financial Results and Highlights Operational Progres..
GL
06/22Affimed to Report First Quarter 2021 Financial Results & Corporate Update July 1, 2021
GL
06/16AFFIMED N : Annual General Meeting Results (Form 6-K)
PU
06/16Affimed N.V. Appoints Denise Mueller to the Management Board
CI
06/16Affimed N.V. Appoints Uta Kemmerich-Keil as Director on Its Supervisory Board
CI
06/16Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board
GL
06/16Affimed N.V. Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board
CI
06/13AFFIMED N : 2021 Annual General Meeting
PU
05/31AFFIMED N : Jefferies Virtual Healthcare Conference
PU
05/26Affimed to Present at the Jefferies Virtual Healthcare Conference 2021
GL
05/26PRESS RELEASE : Affimed to Present at the Jefferies Virtual Healthcare Conference 2021
DJ
05/20Affimed Announces Virtual Annual General Meeting of Shareholders
GL
05/20PRESS RELEASE : Affimed Announces Virtual Annual General Meeting of Shareholders
DJ
05/13Affimed Announces Publication of Preclinical Data in Clinical Cancer Research Supportin..
GL
05/13PRESS RELEASE : Affimed Announces Publication of -2-
DJ
05/13PRESS RELEASE : Affimed Announces Publication of Preclinical Data in Clinical Cancer Resea..
DJ
05/13Affimed N.V. Announces Publication of Preclinical Data in Clinical Cancer Research Supp..
CI
04/29PRESS RELEASE : Heidelberg Pharma AG: Interim Management Statement on the First Three Mont..
DJ
04/21AFFIMED N : Amendment to Annual Report by Foreign Issuer (SEC Filing - 20-F/A)
PU
04/16XOMA : Royalty Portfolio Grows with Addition of Three Royalty Assets
AQ
04/15XOMA : Adds Three Royalty Assets From Affimed
MT
04/15AFFIMED N : Reports FY20 Loss; Revenue Declines
MT
04/15Affimed N.V. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
04/15Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress
GL
04/15PRESS RELEASE : Affimed Reports 2020 Financial -2-
DJ
04/15PRESS RELEASE : Affimed Reports 2020 Financial -3-
DJ
04/15PRESS RELEASE : Affimed Reports 2020 Financial Results and Highlights Recent Operational P..
DJ
04/13AFFIMED N : Fourth Quarter 2020 Financial Results and Corporate Update Conference Call
PU
04/13CONFERENCE CALL : AACR, data presented on cbNK cells pre-complexed with AFM13
PU
04/13Certain Warrants of Affimed N.V. are subject to a Lock-Up Agreement Ending on 13-APR-20..
CI
04/13Certain Common Shares of Affimed N.V. are subject to a Lock-Up Agreement Ending on 13-A..
CI
04/13Certain Options of Affimed N.V. are subject to a Lock-Up Agreement Ending on 13-APR-202..
CI
04/12AFFIMED N : BMO Capital Adjusts Affimed's Price Target to $15 From $12, Keeps Outperform R..
MT
04/12Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targeting The..
GL
04/12PRESS RELEASE : Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-..
DJ
04/12Affimed N.V. Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targetin..
CI
04/09SECTOR UPDATE : Health Care Stocks Continue to Gain Strength Ahead of Closing Bell
MT
04/09SECTOR UPDATE : Health Care Stocks Maintaining Small Friday Advance
MT
04/09MIDDAY REPORT : Wall Street Firmer Midday Amid Producer Prices Spike
MT
04/09Wall Street Treads Water Pre-Bell, US PPI Up 1% in March
MT
04/09US Futures Cautiously Higher; Producer Prices Eyed
MT
04/09AFFIMED N : to Report Full Year 2020 Financial Results & Corporate Update on April 15, 202..
AQ
04/09PRESS RELEASE : Affimed Announces Presentation at AACR Highlighting Initial Data from Phas..
DJ
04/09PRESS RELEASE : Affimed Announces Presentation at -2-
DJ
04/09Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of ..
GL
04/09Affimed N.V. Announces Presentation at AACR Highlighting Initial Data from Phase 1 Stud..
CI
04/08Affimed to Report Full Year 2020 Financial Results & Corporate Update on April 15, 202..
GL
04/08PRESS RELEASE : Affimed to Report Full Year 2020 Financial Results & Corporate Update on A..
DJ
04/01AFFIMED N : and NKMax America Announce FDA Clearance of IND Application to Study the Combi..
AQ
03/31AFFIMED N : Credit Suisse Starts Affimed at Outperform with $15 Price Target
MT
03/31SECTOR UPDATE : Health Care Stocks Mostly Flat Ahead of Wednesday's Market Open
MT
03/31AFFIMED N : NKMax America's Joint New Drug Application Targeting Tumor Patients Gets FDA N..
MT
03/31PRESS RELEASE : Affimed and NKMax America Announce FDA Clearance of IND Application to Stu..
DJ
03/31Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combin..
GL
1  2  3  4  5  6Next
Upcoming event on AFFIMED N.V.
11/02/21